Promopharm SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Promopharm SA with three other
pharmaceutical manufacturers in Africa:
Societe Adwya SA
sales of 108.18 million Dinar [US$37.93 million]
of which 59%
Fidson Healthcare Limited
(16.23 billion Naira [US$52.91 million]
Glaxo Smithkline Consumer Nigeria PLC
based in Nigeria
(18.41 billion Naira [US$60.02 million]
of which 65%
Promopharm SA reported sales of 444.53 million Moroccan Dirhams (US$46.16 million)
December of 2018.
decrease of 13.0%
versus 2017, when the company's sales were 511.20 million Moroccan Dirhams.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Promopharm SA had sales
of 449.18 million Moroccan Dirhams.